Preimplantation genetic testing (PGT) is a way to screen embryos for certain genetic conditions before implantation. It’s usually done as part of in vitro fertilization (IVF), a process where eggs are fertilized with sperm in a lab. PGT can be used to test for a specific genetic condition, such as cystic fibrosis, or to select an embryo that’s a match for a donor.
The major drivers of growth for this market are the increasing incidence of genetic disorders, the rising number of IVF procedures, and the growing awareness of preimplantation genetic testing. In addition, the availability of new technology and improved methods of preimplantation genetic testing are expected to drive market growth over the forecast period. However, some factors could restrain market growth, such as ethical concerns about preimplantation genetic testing, its high cost, and the lack of skilled personnel.
The global preimplantation genetic testing market outlook study is a comprehensive databook that provides key market data on the global preimplantation genetic testing industry. Some of the prominent players in the market are Abbott Laboratories, Agilent Technologies, Beijing Genomics Institute, Combimatrix, Coopersurgical, Genea Limited, Good Start Genetics, Illumina, Invicta Genetics, Natera, Oxford Gene Technology, Perkinelmer, Progenesis, Rubicon Genomics, Scigene, Thermo Fisher, Yikon Genomics. The research report on the global preimplantation genetic testing market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the market.
Covid-19 Impact Analysis
The Covid-19 pandemic has had a significant impact on the global preimplantation genetic testing market. The outbreak of the pandemic has led to a decrease in the number of IVF procedures being carried out globally, as many IVF clinics have been forced to close their doors due to government restrictions on non-essential medical procedures. This has resulted in a decrease in demand for preimplantation genetic testing services. However, it is important to note that the impact of Covid-19 on the preimplantation genetic testing market is expected to be temporary, as the demand for IVF and PGT services is expected to rebound once the pandemic is over and clinics can resume normal operations.
Goals and Objectives of the Global Preimplantation Genetic Testing Market Study
The purpose of this study is to identify the current market environment for preimplantation genetic testing and to assess the market's potential for growth over the forecast period. The research delves into market factors affecting the preimplantation genetic testing market (drivers, restraints, opportunities, and trends). The current market for preimplantation genetic testing is examined in this report, as well as the market's future trajectory.
- The reasons for doing this study are to:
- To generate a detailed industry structure, provide a comprehensive analysis of the preimplantation genetic testing market industry and its segments in the global market.
- Provide detailed insights into the factors driving and restraining the global market for preimplantation genetic testing growth.
- Estimate the size of the global market for preimplantation genetic testing.
- Examine the global market for preimplantation genetic testing in terms of key countries and regions.
- Provide country-level market value analysis for key segments of the preimplantation genetic testing market.
- Provide strategic profiling of key global companies, as well as a thorough analysis of their competitiveness and the overall competitive landscape in this market.
The second chapter, market overview, provides an overview of the preimplantation genetic testing market. The chapter discusses macroeconomic factors, drivers, restraints, opportunities, challenges, value chain analysis, technology roadmap, and Porter 5 force model analysis.
Scope of the Report
The global preimplantation genetic testing market is extensive, with a detailed description and evaluation of the market. It includes extensive qualitative and quantitative insights into the report that are aligned with our intended customers' goals and objectives.
| Attribute |
Description |
| Base Year |
2022 |
| Historical Year |
2019 - 2021 |
| Forecast Period |
2023 - 2029 |
| Market Value |
US$ Million |
| Segments Covered |
By Product Type: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis.
By Application: Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic Institutes.
|
| Geographies Covered |
North America: U.S., Canada
Europe: Germany, U.K., France, Italy, Spain, Russia, and the Rest of Europe
Asia Pacific: China, India, Japan, Australia, and the Rest of Asia Pacific
The Middle East and Africa: GCC, South Africa, and the Rest of Middle East and Africa
Latin America: Brazil, Mexico, and the Rest of Latin America
|
| Companies |
Abbott Laboratories, Agilent Technologies, Beijing Genomics Institute, Combimatrix, Coopersurgical, Genea Limited, Good Start Genetics, Illumina, Invicta Genetics, Natera, Oxford Gene Technology, Perkinelmer, Progenesis, Rubicon Genomics, Scigene, Thermo Fisher, Yikon Genomics |
Global Preimplantation Genetic Testing Market Segmentation
Chapter 3, segment analysis provides information on the different sub-segments of the market. The chapter provides an in-depth analysis of the market segments and year-on-year growth projections that enable readers to identify potential market growth areas.
- Based on product type, the global preimplantation genetic testing market is segmented into preimplantation genetic screening, preimplantation genetic diagnosis.
- Based on application, the preimplantation genetic testing market is segmented into maternity centers & fertility clinics, hospitals, diagnostic labs, and service providers, research laboratories & academic institutes.
Global Preimplantation Genetic Testing Market Regional Analysis
Chapter 4, the regional analysis includes an in-depth analysis of the preimplantation genetic testing market by region. The chapter covers several regions, including North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The report also includes a comprehensive analysis of the market by country. The report covers countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers to explore the potential of the market in different geographies. This section is a vital part of the report for each year’s growth projections and a global share of value.
Global Preimplantation Genetic Testing Market Competitive Analysis
Chapter 5, a competitive analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.
Global Preimplantation Genetic Testing Market Company Profile
Chapter 6, the company profile of the report also covers key industry players working in the preimplantation genetic testing market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.
Sources of Information
- Primary Research: Email correspondence and phone interviews are two common methods of conducting primary research. Primary interviews aid in the validation of data and information, the development of secondary sources, and the collection of data for market nodes where secondary sources are unavailable. Participants in this type of process typically include:
- CEOs, VPs, marketing/product managers, market intelligence managers, and national sales managers are among the industry participants.
- External experts include investment bankers, valuation specialists, and research analysts who specialize in specific medical equipment markets.
- Secondary Research: The research process entails conducting extensive secondary research on internal and external sources to gather qualitative and quantitative market information. The first step in the secondary research is to prepare a list of companies and product mapping for market nodes. The next step is to collect data and information from the public domain for the market nodes. The following are examples of secondary research sources:
- Financial reports, broker reports, investor presentations, and SEC filings.
- Journals of industry, scientific journals, and other technical literature
- Patent and regulatory databases that are relevant.
- Documents from the national government and statistical databases
- News articles, press releases, and webcasts specific to market participants.
